Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden
· Delayed Price · Currency is SEK 3.120
-0.040 (-1.27%)
At close: Apr 28, 2026
Bio-Works Technologies AB Market Cap
Bio-Works Technologies AB has a market cap or net worth of 310.20 million as of April 29, 2026. Its market cap has increased by 228.85% in one year.
Market Cap
310.20M
Enterprise Value
275.27M
Revenue
63.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.12
Market Cap Chart
Since December 14, 2017, Bio-Works Technologies AB's market cap has increased from 241.45M to 310.20M, an increase of 28.48%. That is a compound annual growth rate of 3.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mendus AB | 311.04M |
| Sprint Bioscience AB | 328.15M |
| Ascelia Pharma AB | 383.78M |
| Corline Biomedical AB | 409.82M |
| Intervacc AB | 411.70M |
| Xintela AB | 228.24M |
| Isofol Medical AB | 225.63M |
| Initiator Pharma | 214.26M |